Semaglutide is the GLP-1 receptor agonist that started the category. It mimics a gut hormone that reduces appetite and slows gastric emptying. In the STEP-1 trial of FDA-approved branded semaglutide (Wegovy® 2.4 mg weekly), participants averaged a 14.9% body-weight reduction at 68 weeks. OPTML dispenses semaglutide as a compounded preparation, prescribed by U.S.-licensed providers and filled by our 503A pharmacy partners.
STEP-1 studied FDA-approved branded semaglutide, not compounded preparations. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
Compounded medication is not FDA-approved. Starting at $249/mo · HSA/FSA eligible.
LegitScript CertifiedHealthcare Merchant
Prescription only
✓ Licensed US providers✓ 2-3 day discreet shipping✓ Cancel anytime
LegitScript CertifiedHealthcare Merchant
Semaglutide is a GLP-1 receptor agonist — the molecule that started the GLP-1 category. In the STEP-1 trial of FDA-approved branded semaglutide (Wegovy® 2.4 mg weekly), participants averaged a 14.9% body-weight reduction at 68 weeks. OPTML dispenses semaglutide as a compounded preparation, prescribed by U.S.-licensed providers and filled by our licensed 503A pharmacy partners (Strive · Boothwyn · Absolute).
STEP-1 studied FDA-approved branded semaglutide, not compounded preparations. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results vary.
GLP-1 Muscle Loss Protocol included
Resistance-training program built around GLP-1 weight loss — because losing fat without muscle is the goal. No other compounded-GLP-1 provider includes this.
Starting at $249/mo · Free provider consult · HSA/FSA eligible
STEP-1 Trial · 68 weeks · Branded semaglutide
In the STEP-1 trial of FDA-approved branded semaglutide, participants averaged a 14.9% body-weight reduction over 68 weeks at the 2.4 mg weekly dose.*
*STEP-1 studied FDA-approved branded semaglutide (Wegovy® 2.4 mg). Compounded preparations are not FDA-approved or evaluated by FDA. Individual results vary. Educational reference only.
Semaglutide is a once-weekly injectable GLP-1 receptor agonist that mimics a hormone your body already produces — slowing gastric emptying, reducing appetite, and improving insulin sensitivity. In clinical trials of the FDA-approved branded preparations (Ozempic® for type 2 diabetes; Wegovy® for chronic weight management, both manufactured by Novo Nordisk), semaglutide became the most-prescribed GLP-1 receptor agonist in the world.
The same molecule can also be prepared by licensed 503A compounding pharmacies as a personalized prescription. OPTML’s compounded semaglutide is prescribed by U.S.-licensed providers and filled by our 503A pharmacy partners (Strive · Boothwyn · Absolute) under USP <797> sterility standards, then shipped to your door monthly. Compounded preparations are not FDA-approved or evaluated by FDA for safety, effectiveness, or quality.
Ozempic® and Wegovy® are FDA-approved branded preparations of semaglutide, manufactured by Novo Nordisk and sold for ~$1,300+/mo cash. A licensed 503A pharmacy can also prepare the same molecule as a personalized compounded prescription, made to a provider’s specifications.
What’s different: price ($249/mo flat), access (2-3 days vs 4-8 weeks), and personalization. The active pharmaceutical ingredient is chemically identical; the compounded preparation is not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded drugs.
Semaglutide activates one receptor: GLP-1. Tirzepatide activates two: GIP and GLP-1. The dual mechanism gives tirzepatide a stronger absolute weight-loss number, but semaglutide is gentler, has more long-term safety data, and works well for patients who don’t need maximum titration.
In trials of the FDA-approved branded preparations: branded semaglutide produced an average 14.9% body-weight reduction (STEP-1, 68 wk) and branded tirzepatide produced an average 20.9% (SURMOUNT-1, 72 wk). If you’d rather start gentler, semaglutide is the right place to begin.
STEP-1 (NEJM 2021, n=1,961) was the pivotal trial of FDA-approved branded semaglutide. Over 68 weeks on the 2.4 mg weekly dose of branded semaglutide, participants lost an average of 14.9% of body weight, with 86% losing at least 5%, and average waist circumference reduction of ~3.6 inches. The trial studied the FDA-approved branded preparation, not compounded preparations.
Source: Wilding JPH et al. New England Journal of Medicine. STEP-1. 2021.
$249/mo
all-inclusive flat retail
$1,349/mo
Wegovy cash retail
The active pharmaceutical ingredient (semaglutide) is chemically identical to that used in the FDA-approved branded products. Compounded preparations are not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Prescribed by U.S.-licensed providers and prepared by licensed 503A compounding pharmacies under USP <797> sterility standards. Wegovy® retail price as of May 2026.
No surprises, no upsells. Each shipment includes everything you need to administer safely at home, plus full clinical support.
The pivotal STEP-1 trial that earned semaglutide its weight-loss indication. 68-week randomized study, dosed to 2.4 mg weekly.
Source: Wilding JPH et al. New England Journal of Medicine. STEP-1 Trial. 2021.
Online assessment to first shipment in under a week. No in-person visits, no waiting rooms.
Start your free assessment →Answer a few questions about your health, weight history, and goals. Takes about 5 minutes online.
A U.S. licensed provider reviews your assessment and prescribes the right dose, if appropriate. You'll hear back from your provider.
If prescribed, your compounded semaglutide, syringes, and supplies ship discreetly in 2-3 days. Free 2-3 day shipping always.
Self-administer at home. Most patients report reduced cravings and steady weight loss within 2-4 weeks.
Message your provider anytime. Dose adjustments, refills, and side-effect questions handled in-app. Cancel anytime.
Question 1 of 12
Start losing weight in 5 simple steps
Answer a few questions about your health, weight history, and goals — about 5 minutes, all online.
No commitment. No insurance needed. See full eligibility & contraindications →
Based on aggregate clinical-trial data (STEP-1, NEJM 2022). Individual results vary.
Most patients report reduced cravings and earlier fullness within the first two doses. Mild nausea is common; usually fades within a week.
By the end of month one, average reduction is 3-5% of body weight. Energy stabilizes. Provider checks in to titrate dose.
Average reduction reaches 7-10% by month three. Most patients are at full therapeutic dose by now. Body composition shifts; not just water.
By month six most reach 13-18% reduction. Appetite suppression is sustained. Maintenance dosing discussion begins around month nine.
Source: Wilding JPH et al. NEJM 2021 (STEP-1, n=1,961, 68 weeks). 2.4 mg weekly semaglutide produced average −14.9% body weight reduction at 68 weeks vs −2.4% placebo.
Same active ingredient. Same molecule. Roughly $1,100 less per month, available in days instead of weeks, no insurance maze required. Compounded preparations are not FDA-approved.
*Branded Wegovy® 2.4 mg cash price as listed on the Novo Nordisk patient resources page, May 2026 (without insurance or eligibility-restricted savings card). Insurance-covered cost varies by plan and often requires prior authorization. Compounded preparations are not FDA-approved or evaluated by the FDA for safety, effectiveness, or quality.
Provider consult, compounded medication, syringes, and unlimited messaging, all included.
As your provider titrates your dose from 0.25 mg up to 2.4 mg, your monthly price never changes. No tier upgrades, no dose surcharges, no surprise bills.
Same price at every dose — 0.25 mg → 2.4 mg.
Your physician titrates your dose based on your response. Most patients reach the optimal therapeutic dose by month 4–5.
Your monthly price includes everything.
Physician consultation, prescription, and ongoing medical oversight. No hidden fees. No separate membership. Just your optml protocol.
Billed monthly. Cancel anytime.
Prescribed by board-certified U.S.-licensed clinicians
Licensed in all 50 states · Meet your care team
Free calculators and quizzes built around real clinical data. Use them as often as you want.
Goal date
When will you hit your goal weight?
GLP-1 cost
What you'll actually spend on GLP-1s this year
Savings
How much would you save with OPTML?
BMI
BMI & eligibility check
Match quiz
Find my protocol — match in 90 seconds
Deficit
Daily calorie deficit for your goal
TDEE
Total daily energy expenditure
BMR
Basal metabolic rate
Protein
Daily protein target for your goal
5-minute online consult. Provider review in 24 hours. First shipment in under a week.
LegitScript CertifiedHealthcare Merchant
5-minute online consult. Provider review in 24 hours. First shipment in under a week.